Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Journal of Molecular Biology
|
January 29, 2008
Designed armadillo repeat proteins as general peptide-binding scaffolds: consensus design and computational optimization of the hydrophobic core
Fabio Parmeggiani, Riccardo Pellarin, Anders Peter Larsen, et al.
The Journal of Biological Chemistry
|
April 27, 2005
Intracellular kinase inhibitors selected from combinatorial libraries of designed ankyrin repeat proteins
Patrick Amstutz, H Kaspar Binz, Petra Parizek, et al.
Nature Biotechnology
|
April 21, 2004
High-affinity binders selected from designed ankyrin repeat protein libraries
H Kaspar Binz, Patrick Amstutz, Andreas Kohl, et al.
Oncotarget
|
December 13, 2017
MP0250, a VEGF and HGF neutralizing DARPin<sup>®</sup> molecule shows high anti-tumor efficacy in mouse xenograft and patient-derived tumor models
Ulrike Fiedler, Savira Ekawardhani, Andreas Cornelius, et al.
American Journal of Ophthalmology
|
December 11, 2012
Treatment of diabetic macular edema with a designed ankyrin repeat protein that binds vascular endothelial growth factor: a phase I/II study
Peter A Campochiaro, Roomasa Channa, Brian B Berger, et al.
American Journal of Ophthalmology
|
June 8, 2014
Treatment of exudative age-related macular degeneration with a designed ankyrin repeat protein that binds vascular endothelial growth factor: a phase I/II study
Eric H Souied, François Devin, Martine Mauget-Faÿsse, et al.
Protein Engineering, Design & Selection : PEDS
|
November 1, 2017
Half-life extension using serum albumin-binding DARPin® domains
Daniel Steiner, Frieder W Merz, Ivo Sonderegger, et al.
Cancer Research
|
February 4, 2010
Efficient tumor targeting with high-affinity designed ankyrin repeat proteins: effects of affinity and molecular size
Christian Zahnd, Martin Kawe, Michael T Stumpp, et al.
Angiogenesis
|
September 18, 2012
Highly potent VEGF-A-antagonistic DARPins as anti-angiogenic agents for topical and intravitreal applications
Andreas Stahl, Michael T Stumpp, Anja Schlegel, et al.
Angiogenesis
|
October 25, 2013
Antagonism of PDGF-BB suppresses subretinal neovascularization and enhances the effects of blocking VEGF-A
Aling Dong, Christopher Seidel, Daniel Snell, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Journal of Molecular Biology
|
January 29, 2008
Designed armadillo repeat proteins as general peptide-binding scaffolds: consensus design and computational optimization of the hydrophobic core
Fabio Parmeggiani, Riccardo Pellarin, Anders Peter Larsen, et al.
The Journal of Biological Chemistry
|
April 27, 2005
Intracellular kinase inhibitors selected from combinatorial libraries of designed ankyrin repeat proteins
Patrick Amstutz, H Kaspar Binz, Petra Parizek, et al.
Nature Biotechnology
|
April 21, 2004
High-affinity binders selected from designed ankyrin repeat protein libraries
H Kaspar Binz, Patrick Amstutz, Andreas Kohl, et al.
Oncotarget
|
December 13, 2017
MP0250, a VEGF and HGF neutralizing DARPin<sup>®</sup> molecule shows high anti-tumor efficacy in mouse xenograft and patient-derived tumor models
Ulrike Fiedler, Savira Ekawardhani, Andreas Cornelius, et al.
American Journal of Ophthalmology
|
December 11, 2012
Treatment of diabetic macular edema with a designed ankyrin repeat protein that binds vascular endothelial growth factor: a phase I/II study
Peter A Campochiaro, Roomasa Channa, Brian B Berger, et al.
American Journal of Ophthalmology
|
June 8, 2014
Treatment of exudative age-related macular degeneration with a designed ankyrin repeat protein that binds vascular endothelial growth factor: a phase I/II study
Eric H Souied, François Devin, Martine Mauget-Faÿsse, et al.
Protein Engineering, Design & Selection : PEDS
|
November 1, 2017
Half-life extension using serum albumin-binding DARPin® domains
Daniel Steiner, Frieder W Merz, Ivo Sonderegger, et al.
Cancer Research
|
February 4, 2010
Efficient tumor targeting with high-affinity designed ankyrin repeat proteins: effects of affinity and molecular size
Christian Zahnd, Martin Kawe, Michael T Stumpp, et al.
Angiogenesis
|
September 18, 2012
Highly potent VEGF-A-antagonistic DARPins as anti-angiogenic agents for topical and intravitreal applications
Andreas Stahl, Michael T Stumpp, Anja Schlegel, et al.
Angiogenesis
|
October 25, 2013
Antagonism of PDGF-BB suppresses subretinal neovascularization and enhances the effects of blocking VEGF-A
Aling Dong, Christopher Seidel, Daniel Snell, et al.
Page
of 3